Format

Send to

Choose Destination
Am J Hematol. 2019 May;94(5):E146-E149. doi: 10.1002/ajh.25441. Epub 2019 Mar 6.

Bone marrow biopsy in low-risk monoclonal gammopathy of undetermined significance reveals a novel smoldering multiple myeloma risk group.

Author information

1
Center for Prevention of Progression of Blood Cancers, Dana-Farber Cancer Institute, Boston, Massachusetts.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
3
Department of Clinical Therapeutics, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece.
4
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
PMID:
30773670
DOI:
10.1002/ajh.25441

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center